Fate Therapeutics, Inc. earnings per share and revenue

FATE earnings per share for the last quarter are -0.40 USD whereas the estimation was -0.42 USD which accounts for 3.95% surprise. Company revenue for the same period amounts to 3.07 M USD despite the estimated figure of 1.24 M USD. Estimated earnings per share for the next quarter are -0.44 USD, and revenue is expected to reach 1.62 M USD. Also watch annual changes over time to get a bigger picture of FATE earnings per share and revenue dynamics.